Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1977 1
1980 1
1981 1
1982 1
1983 2
1984 7
1985 2
1986 2
1987 2
1988 4
1989 2
1990 4
1991 9
1992 9
1993 11
1994 15
1995 11
1996 18
1997 8
1998 11
1999 11
2000 14
2001 17
2002 13
2003 18
2004 16
2005 12
2006 23
2007 29
2008 19
2009 33
2010 29
2011 36
2012 37
2013 34
2014 35
2015 48
2016 51
2017 70
2018 69
2019 71
2020 60
2021 69
2022 85
2023 61
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

978 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Malignant Germ Cell Tumor"
Page 1
Brain Tumors.
McFaline-Figueroa JR, Lee EQ. McFaline-Figueroa JR, et al. Am J Med. 2018 Aug;131(8):874-882. doi: 10.1016/j.amjmed.2017.12.039. Epub 2018 Jan 31. Am J Med. 2018. PMID: 29371158 Review.
Meningiomas are tumors of the meninges, mostly benign and often managed by surgical resection, with radiation therapy and chemotherapy reserved for high-risk or refractory disease. Glioblastoma is the most common and aggressive malignant primary brain tumor, …
Meningiomas are tumors of the meninges, mostly benign and often managed by surgical resection, with radiation therapy and chemotherapy reser …
Retinoblastoma.
Rao R, Honavar SG. Rao R, et al. Indian J Pediatr. 2017 Dec;84(12):937-944. doi: 10.1007/s12098-017-2395-0. Epub 2017 Jun 16. Indian J Pediatr. 2017. PMID: 28620731 Review.
Intra-arterial chemotherapy has emerged as a promising alternative for advanced and refractory retinoblastoma, both as a primary and secondary therapy. Recent advances in genetics of retinoblastoma have also helped in improving the overall clinical management of this ma …
Intra-arterial chemotherapy has emerged as a promising alternative for advanced and refractory retinoblastoma, both as a primary and …
Glioblastoma heterogeneity at single cell resolution.
Eisenbarth D, Wang YA. Eisenbarth D, et al. Oncogene. 2023 Jun;42(27):2155-2165. doi: 10.1038/s41388-023-02738-y. Epub 2023 Jun 5. Oncogene. 2023. PMID: 37277603 Free PMC article. Review.
Glioblastoma (GBM) is one of the deadliest types of cancer and highly refractory to chemoradiation and immunotherapy. One of the main reasons for this resistance to therapy lies within the heterogeneity of the tumor and its associated microenvironment. ...The advanc …
Glioblastoma (GBM) is one of the deadliest types of cancer and highly refractory to chemoradiation and immunotherapy. One of the main …
Merkel cell carcinoma.
Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Becker JC, et al. Nat Rev Dis Primers. 2017 Oct 26;3:17077. doi: 10.1038/nrdp.2017.77. Nat Rev Dis Primers. 2017. PMID: 29072302 Free PMC article. Review.
Merkel cell carcinoma (MCC) is a rare but highly aggressive skin cancer with neuroendocrine features. ...Chemotherapy was the only alternative in advanced-stage or refractory MCC until several clinical trials demonstrated the efficacy of immune-checkpoint inhibitors …
Merkel cell carcinoma (MCC) is a rare but highly aggressive skin cancer with neuroendocrine features. ...Chemotherapy was the only al …
Carcinoid-syndrome: recent advances, current status and controversies.
Ito T, Lee L, Jensen RT. Ito T, et al. Curr Opin Endocrinol Diabetes Obes. 2018 Feb;25(1):22-35. doi: 10.1097/MED.0000000000000376. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 29120923 Free PMC article. Review.
These include new studies on its epidemiology which demonstrate it is increasing in frequency; increasing insights into the pathogenesis of its various clinical manifestations and into its natural history: definition of prognostic factors; new methods to verify its presence; the …
These include new studies on its epidemiology which demonstrate it is increasing in frequency; increasing insights into the pathogenesis of …
Treatment of Pediatric Low-Grade Gliomas.
Sait SF, Giantini-Larsen AM, Tringale KR, Souweidane MM, Karajannis MA. Sait SF, et al. Curr Neurol Neurosci Rep. 2023 Apr;23(4):185-199. doi: 10.1007/s11910-023-01257-3. Epub 2023 Mar 7. Curr Neurol Neurosci Rep. 2023. PMID: 36881254 Free PMC article. Review.
PURPOSE OF REVIEW: Pediatric low-grade gliomas and glioneuronal tumors (pLGG) account for approximately 30% of pediatric CNS neoplasms, encompassing a heterogeneous group of tumors of primarily glial or mixed neuronal-glial histology. This article reviews the treatment of …
PURPOSE OF REVIEW: Pediatric low-grade gliomas and glioneuronal tumors (pLGG) account for approximately 30% of pediatric CNS neoplasms …
High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes.
DuBois SG, Macy ME, Henderson TO. DuBois SG, et al. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-13. doi: 10.1200/EDBK_349783. Am Soc Clin Oncol Educ Book. 2022. PMID: 35522915 Free article. Review.
This group continues to have inadequate cure rates despite multiagent chemotherapy, surgery, high-dose chemotherapy with autologous stem cell rescue, and immunotherapy directed against GD2. We review current efforts to try to improve outcomes in patients with newly diagnos …
This group continues to have inadequate cure rates despite multiagent chemotherapy, surgery, high-dose chemotherapy with autologous stem …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
Distant metastases are present at the diagnosis in 5 % of DTC patients; up to 15 % of patients have recurrences during the follow up, with a survival reduction (70 %-50 %) at 10-year. During tumor progression, the iodide uptake capability of DTC cancer cells can be lost, m …
Distant metastases are present at the diagnosis in 5 % of DTC patients; up to 15 % of patients have recurrences during the follow up, with a …
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
Patients aged 3-21 years with a Lansky or Karnofsky performance score greater than 60 and the presence of recurrent, refractory, or progressive paediatric low-grade glioma after at least one standard therapy were eligible for inclusion. ...No treatment-realted deaths were …
Patients aged 3-21 years with a Lansky or Karnofsky performance score greater than 60 and the presence of recurrent, refractory, or p …
Childhood Medulloblastoma: An Overview.
Suk Y, Gwynne WD, Burns I, Venugopal C, Singh SK. Suk Y, et al. Methods Mol Biol. 2022;2423:1-12. doi: 10.1007/978-1-0716-1952-0_1. Methods Mol Biol. 2022. PMID: 34978683 Review.
Medulloblastoma (MB) is the most common malignant pediatric brain tumor, representing 60% of childhood intracranial embryonal tumors. ...The identification of subtype-specific molecular drivers and pathways presents novel therapeutic targets that could lead t …
Medulloblastoma (MB) is the most common malignant pediatric brain tumor, representing 60% of childhood intracranial embryon …
978 results